Giuseppe Recchi, Affidea Group chief executive
Giuseppe Recchi, Affidea Group chief executive

Affidea Group, a European provider of diagnostic imaging, outpatient and cancer care services, today acquired UK orthopaedic group Fortius Clinic.

Fortius clinic was founded in 2009 and comprises more than 90 specialists. It operates three outpatient and diagnostic clinics in central London, as well as the Fortius Surgical Centre and a specialist joint replacement centre in partnership with Bupa. The company is also used by many Premier League football clubs and is a recognised FIFA Medical Centre of Excellence.

Affidea Group has a network of 280 centres across 15 European countries and treats more than seven million patients annually. The acquisition allows Affidea to branch into the fields of orthopaedic and sports medicine and expand its footprint into the UK healthcare market.

Giuseppe Recchi, Affidea Group chief executive, said: “This acquisition represents a significant step in our growth journey, as it adds one more geography to the existing 15 countries where we operate. It also evidences our strategic ambitions to expand into new markets capitalising on the unique model of high standards in healthcare services which have granted Affidea’s reputation as top provider in diagnostic imaging, outpatient and cancer care services.

“Fortius is a patient-centric organisation whose values and standards of care greatly impressed me. Despite the current critical environment for the national healthcare systems across the world due to Covid-19 pandemic, we will continue to offer outstanding patient care with positive medical outcomes. We will combine Fortius’s excellence and innovation in orthopaedic and musculoskeletal care with Affidea’s world-class clinical standards in order to empower our patients to live a life free from pain and injury.”

Jim McAvoy, Fortius chief executive, added: “Today marks an exciting and pivotal stage in the further growth and development of Fortius. We are proud of our achievements in the orthopaedic and MSK market over the last 12 years and we look forward to a new chapter for the company as part a powerful European group. In Affidea we saw a partner with shared values and a commitment to world class care, innovation and first-class service. We are delighted to be part of the Affidea Group, and look forward to working together on opportunities to grow our presence in the UK and across Europe.”

Date published: March 2, 2021

Subscriber content

To get unlimited access subscribe today


Already a subscriber? Login